Tumour cells contain mitochondria with elevated membrane potentials compare
d with normal cells, and thus this feature provides a selective target for
destroying tumour cells. To improve mitochondrial-based therapies, a better
understanding of the factors involved in regulating mitochondria are requi
red. Since v-fos overexpression has been shown to elevate mitochondrial mem
brane potentials in rat fibroblasts, we investigated whether the human homo
logue, c-fos, was also capable of regulating the mitochondrial membrane pot
ential in cells. Rat fibroblasts transfected with the c-fos gene did not ac
cumulate more rhodamine 123 (Rh123) nor did they retain this Rh123 for exte
nded periods of time compared with their parental line. Moreover, there was
no difference in survival following dequalinium chloride (Deca) treatment
between transfectants and controls. Similarly, reduction of c-fos expressio
n in rat fibroblasts did not significantly alter their mitochondrial membra
ne potential. In addition, human ovarian carcinoma cells, which overexpress
the c-fos gene, did not accumulate more Rh123 nor were they hypersensitive
to Deca compared with their parental line. In another human ovarian carcin
oma cell Line, selection of variants with lower mitochondrial membrane pote
ntial did not alter c-fos mRNA or protein levels. These data suggest that a
lterations in c-fos expression do not regulate the magnitude of the mitocho
ndrial membrane potential.